174 related articles for article (PubMed ID: 34965702)
1. Kikuchi-Fujimoto disease associated with hemophagocytic lymphohistiocytosis following the BNT162b2 mRNA COVID-19 vaccination.
Caocci G; Fanni D; Porru M; Greco M; Nemolato S; Firinu D; Faa G; Scuteri A; La Nasa G
Haematologica; 2022 May; 107(5):1222-1225. PubMed ID: 34965702
[No Abstract] [Full Text] [Related]
2. A rare encounter: Kikuchi-Fujimoto disease presenting atypically after BNT162b2 COVID-19 vaccination: a case report.
Nam KH; Choi Y
Scand J Rheumatol; 2023 Nov; 52(6):705-707. PubMed ID: 37606559
[No Abstract] [Full Text] [Related]
3. Kikuchi-Fujimoto disease associated with systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis: a case report.
Vithoosan S; Karunarathna T; Shanjeeban P; Piranavan P; Matthias T; Gamlaksha D; Liyadipita A; Kulatunga A
J Med Case Rep; 2019 Jun; 13(1):173. PubMed ID: 31167644
[TBL] [Abstract][Full Text] [Related]
4. Kikuchi-Fujimoto disease can present as delayed lymphadenopathy after COVID-19 vaccination.
Kashiwada T; Saito Y; Terasaki Y; Shirakura Y; Shinbu K; Tanaka T; Tanaka Y; Seike M; Gemma A
Hum Vaccin Immunother; 2022 Nov; 18(5):2071080. PubMed ID: 35583472
[TBL] [Abstract][Full Text] [Related]
5. Reactive Hemophagocytic Lymphohistiocytosis-Associated Kikuchi-Fujimoto Disease After a Staphylococcus epidermidis Cutaneous Infection: The First Case Report.
Cao NT; Nguyen HT; Pham VHT; Doan TTP; Le LB; Bui KD; Tran TH; Vu TT; Nguyen CTH
J Clin Rheumatol; 2021 Apr; 27(3):e96-e97. PubMed ID: 31804253
[No Abstract] [Full Text] [Related]
6. Kikuchi-Fujimoto Disease Following COVID-19 Vaccination: Experience at a Population-Based Referral Center.
Craig JW; Farinha P; Jiang A; Lytle A; Skinnider B; Slack GW
Am J Clin Pathol; 2023 Aug; 160(2):114-118. PubMed ID: 37526500
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous Acquired Self-limited Hemophagocytic Lymphohistiocytosis and Kikuchi Necrotizing Lymphadenitis in a 16-Year-Old Teenage Girl: A Case Report and Review of the Literature.
Sykes JA; Badizadegan K; Gordon P; Sokol D; Escoto M; Ten I; Vyas S; Torres A; Levine AM
Pediatr Emerg Care; 2016 Nov; 32(11):792-798. PubMed ID: 26555310
[TBL] [Abstract][Full Text] [Related]
8. A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination.
Park HW; Min GJ; Kim TY; Cho SG
Acta Haematol; 2023; 146(1):65-71. PubMed ID: 36096118
[TBL] [Abstract][Full Text] [Related]
9. Kikuchi-Fujimoto disease complicated with hemophagocytic lymphohistiocytosis.
Scarcella A; Marrani E; Coniglio ML; Simonini G; Sieni E
Pediatr Blood Cancer; 2023 Jun; 70(6):e30222. PubMed ID: 36715142
[No Abstract] [Full Text] [Related]
10. Kikuchi-Fujimoto Disease and COVID-19 vaccination: pharmacovigilance approach.
Rodríguez-Ferreras A; Maray I; Coya-Fernández C; Octavio-Bocigas MM; Fernández-Del Río MF; Casares-López S; Ruiz-Salazar J
Eur Ann Allergy Clin Immunol; 2023 Nov; 55(6):278-282. PubMed ID: 36458479
[No Abstract] [Full Text] [Related]
11. An unusual case of Kikuchi-Fujimoto disease presenting as haemophagocytic lymphohistiocytosis.
Shah K; Amarnani R; Owen L; Manson J; Jones A
Br J Hosp Med (Lond); 2021 Sep; 82(9):1-5. PubMed ID: 34601936
[No Abstract] [Full Text] [Related]
12. Kikuchi-Fujimoto disease following SARS-CoV-2 vaccination.
Ikeda K; Kakehi E; Adachi S; Kotani K
BMJ Case Rep; 2022 Nov; 15(11):. PubMed ID: 36414349
[TBL] [Abstract][Full Text] [Related]
13. Kikuchi-Fujimoto disease type lymph node reaction with increased plasmacytoid dendritic cells may appear as a side effect following COVID-19 vaccination: Report of a case and literature review.
Moreno de Juan G; Pérez Del Barrio A; Herrera Romero EG; González Ruiz M; Montes Moreno S
Rev Esp Patol; 2024; 57(1):42-47. PubMed ID: 38246709
[TBL] [Abstract][Full Text] [Related]
14. An analysis of reported cases of hemophagocytic lymphohistiocytosis (HLH) after COVID-19 vaccination.
Zhang HQ; Cao BZ; Cao QT; Hun M; Cao L; Zhao MY
Hum Vaccin Immunother; 2023 Aug; 19(2):2263229. PubMed ID: 37811764
[TBL] [Abstract][Full Text] [Related]
15. [Kikuchi-Fujimoto disease (histiocytic necrotizing lymphadenitis)].
Calvo Romero JM
Rev Clin Esp; 2002 Feb; 202(2):94-5. PubMed ID: 11996763
[No Abstract] [Full Text] [Related]
16. Haemophagocytic lymphohistiocytosis following COVID-19 mRNA vaccination.
Wu V; Lopez CA; Hines AM; Barrientos JC
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35296502
[TBL] [Abstract][Full Text] [Related]
17. Kikuchi disease with cutaneous involvement complicated by features of hemophagocytic lymphohistiocytosis.
Treichel AM; Teske N; Vandergriff T; Dominguez A; Mauskar MM; Nguyen KD
J Cutan Pathol; 2021 Mar; 48(3):343-346. PubMed ID: 33470433
[No Abstract] [Full Text] [Related]
18. Disseminated Kikuchi disease associated with hemophagocytic syndrome in an infant: whole-body MRI.
Kim HA; Im SA; Chung NG; Kang JH; Park GS
Indian J Pediatr; 2011 May; 78(5):616-9. PubMed ID: 21069584
[TBL] [Abstract][Full Text] [Related]
19. A challenging case of Kikuchi-Fujimoto disease with systemic lupus erythematosus complicated with hemophagocytic lymphohistiocytosis in a young man.
Pradhan S; Sirka CS; Dash G; Sahu K; Rout AN
Indian J Dermatol Venereol Leprol; 2021; 87(1):78-82. PubMed ID: 33580926
[No Abstract] [Full Text] [Related]
20. COVID-19 associated Kikuchi-Fujimoto disease.
Stimson L; Stitson R; Bahhadi-Hardo M; Renaudon-Smith E
Br J Haematol; 2021 Mar; 192(5):e124-e126. PubMed ID: 33289068
[No Abstract] [Full Text] [Related]
[Next] [New Search]
